Sandsynligheden for metaboliske stofinteraktioner med lamivudin er lav på grund af begrænset (5 - 10%) levermetabolisme og lav plasmaproteinbinding.
The likelihood of metabolic substance interactions with lamivudine is low due to the small (5-10%) extent of hepatic metabolism and the low plasma protein binding.